Publishing research using ab124812? Please let us know so that we can cite the reference in this datasheet.

ab124812 has been referenced in 7 publications.

  • Wang JB  et al. A systems pharmacology-oriented discovery of a new therapeutic use of the TCM formula Liuweiwuling for liver failure. Sci Rep 8:5645 (2018). PubMed: 29618826
  • Meng H  et al. Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis. Proc Natl Acad Sci U S A 115:E2001-E2009 (2018). PubMed: 29440439
  • Zhang X  et al. Dominant Negative FADD/MORT1 Inhibits the Development of Intestinal Intraepithelial Lymphocytes With a Marked Defect on CD8aa+TCR?d+ T Cells. Front Immunol 9:2038 (2018). PubMed: 30250469
  • Geng J  et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat Commun 8:359 (2017). PubMed: 28842570
  • Wang H  et al. PELI1 functions as a dual modulator of necroptosis and apoptosis by regulating ubiquitination of RIPK1 and mRNA levels of c-FLIP. Proc Natl Acad Sci U S A 114:11944-11949 (2017). PubMed: 29078411
  • Bowman BM  et al. Phosphorylation of FADD by the kinase CK1a promotes KRASG12D-induced lung cancer. Sci Signal 8:ra9 (2015). PubMed: 25628462
  • Jaiswal MK  et al. Regulation of apoptosis and innate immune stimuli in inflammation-induced preterm labor. J Immunol 191:5702-13 (2013). WB, IHC-Fr ; Mouse . PubMed: 24163412

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up